Clinical Trial Detail

NCT ID NCT02476968
Title To Assess the Efficacy and Safety of Olaparib Maintenance Monotherapy in the Treatment of Ovarian Cancer (ORZORA)
Recruitment Active, not recruiting
Gender female
Phase FDA approved
Variant Requirements Yes
Sponsors AstraZeneca
Indications

fallopian tube cancer

peritoneum cancer

ovarian cancer

Therapies

Olaparib

Age Groups: senior adult

Additional content available in CKB BOOST